hefi-1
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 1999 (NCT00003741)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor necrosis factor receptor superfamily member 8BINDING AGENT
TNFRSF8 binding agent
TNFRSF8 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109255 ↗
Also known as
- hefi-1
- hefi-1
- monoclonal antibody hefi-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00048880 | Phase 1 | Nov 5, 2002 | National Cancer Institute (NCI) |
| NCT00003741 | Phase 1 | Feb 1, 1999 | Harvard University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 1999 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2002 |
2 organizations
Page 1 / 1